apigenin

apigenin is a lipid of Polyketides (PK) class. Apigenin is associated with abnormalities such as Morphologically altered structure, Chimera disorder, Hypertensive disease, infection induced and Infection. The involved functions are known as inhibitors, Gene Expression, Process, Metabolic Inhibition and Cell Death. Apigenin often locates in Vacuole, Cytoplasmic matrix, Cytoplasm, Tissue membrane and Membrane. The associated genes with apigenin are MSMP gene, BCL2 gene, PTGS2 gene, Chromatin and SLC33A1 gene. The related lipids are Lipopolysaccharides, Steroids, 1-Butanol, agosterol A and Butyrates. The related experimental models are Mouse Model, Tissue Model, Knock-out, Xenograft Model and Disease model.

Cross Reference

Introduction

To understand associated biological information of apigenin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with apigenin?

apigenin is suspected in Pneumonia, Morphologically altered structure, Hypertensive disease, Dermatitis, Infection, Senile Plaques and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with apigenin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Gastritis D005756 27 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Brain Infarction D020520 17 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Translocation, Genetic D014178 20 associated lipids
Leiomyoma D007889 8 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Parkinson Disease D010300 53 associated lipids
Glioblastoma D005909 27 associated lipids
Cystitis D003556 23 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Insulin Resistance D007333 99 associated lipids
Encephalitis D004660 15 associated lipids
Weight Loss D015431 56 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Memory Disorders D008569 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Cocaine-Related Disorders D019970 3 associated lipids
Premature Birth D047928 6 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Genomic Instability D042822 7 associated lipids
Prostatic Neoplasms, Castration-Resistant D064129 3 associated lipids
Chromosomal Instability D043171 5 associated lipids
Lymphoma, Primary Effusion D054685 2 associated lipids
Per page 10 20 50 100 | Total 64

PubChem Associated disorders and diseases

What pathways are associated with apigenin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with apigenin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with apigenin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with apigenin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with apigenin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with apigenin?

Mouse Model

Mouse Model are used in the study 'Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation.' (Nicholas C et al., 2007), Mouse Model are used in the study 'Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study.' (Kaur P et al., 2008) and Mouse Model are used in the study 'Apigenin alleviates the symptoms of Staphylococcus aureus pneumonia by inhibiting the production of alpha-hemolysin.' (Dong J et al., 2013).

Xenograft Model

Xenograft Model are used in the study 'Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma.' (Torkin R et al., 2005).

Tissue Model

Tissue Model are used in the study 'Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium.' (Lim R et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with apigenin

Download all related citations
Per page 10 20 50 100 | Total 2777
Authors Title Published Journal PubMed Link
Sui H et al. [Effect of high dose apigenin on antioxidase activity and DNA damage in rats]. 2009 Wei Sheng Yan Jiu pmid:19267072
Sui H et al. [Endothelium-dependent vasorelaxation effects induced by apigenin on the thoracic aorta of rats and its possible mechanism]. 2011 Wei Sheng Yan Jiu pmid:21861336
Chang CW et al. Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. 2012 Viruses pmid:22590685
Qian S et al. Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity. 2015 Viruses pmid:25835532
Shibata C et al. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels. 2014 Virology pmid:25092460
Qin W et al. Apigenin and naringenin ameliorate PKCβII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. 2016 Vascul. Pharmacol. pmid:27473516
Chen F et al. An efficient approach for the extraction of orientin and vitexin from Trollius chinensis flowers using ultrasonic circulating technique. 2017 Ultrason Sonochem pmid:28427633
Kawamura H et al. Ultrasonically enhanced extraction of luteolin and apigenin from the leaves of Perilla frutescens (L.) Britt. using liquid carbon dioxide and ethanol. 2016 Ultrason Sonochem pmid:26584980
Medhat AM et al. Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice. 2017 Tumour Biol. pmid:29022496
Hassoun SM et al. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway. 2017 Tumour Biol. pmid:28651490
Chen J et al. The apoptotic effect of apigenin on human gastric carcinoma cells through mitochondrial signal pathway. 2014 Tumour Biol. pmid:24805829
Wan Y et al. miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway. 2017 Tumour Biol. pmid:28381178
Nasr-Bouzaiene N et al. Immunomodulatory and cellular antioxidant activities of pure compounds from Teucrium ramosissimum Desf. 2016 Tumour Biol. pmid:26692099
Ahlenstiel T et al. Improved cold preservation of kidney tubular cells by means of adding bioflavonoids to organ preservation solutions. 2006 Transplantation pmid:16436967
Ibanez S et al. Plant insecticidal toxins in ecological networks. 2012 Toxins (Basel) pmid:22606374
Huang H et al. effects of natural flavonoids on photosynthetic activity and cell integrity in Microcystis aeruginosa. 2015 Toxins (Basel) pmid:25584428
Schrader KK Plant Natural compounds with antibacterial activity towards common pathogens of pond-cultured channel catfish (Ictalurus punctatus). 2010 Toxins (Basel) pmid:22069655
Zhong Y et al. Apigenin attenuates patulin-induced apoptosis in HEK293 cells by modulating ROS-mediated mitochondrial dysfunction and caspase signal pathway. 2017 Toxicon pmid:28734981
Yingprasertchai S et al. Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. 2003 Toxicon pmid:14602119
Çelik H et al. In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (-)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase. 2013 Toxicology pmid:23567315
Androutsopoulos VP et al. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. 2009 Toxicology pmid:19666078
Chaudhary A and Willett KL Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort. 2006 Toxicology pmid:16271822
Khan TH and Sultana S Apigenin induces apoptosis in Hep G2 cells: possible role of TNF-alpha and IFN-gamma. 2006 Toxicology pmid:16289292
Sanderson JT et al. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. 2004 Toxicol. Sci. pmid:15319488
Jin UH et al. Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids. 2018 Toxicol. Sci. pmid:29584932
Alhusainy W et al. Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically based biokinetic modeling of possible in vivo effects. 2012 Toxicol. Sci. pmid:22649189
Hong H et al. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. 2015 Toxicol. Sci. pmid:25349334
Barlas N et al. The estrogenic effects of apigenin, phloretin and myricetin based on uterotrophic assay in immature Wistar albino rats. 2014 Toxicol. Lett. pmid:24487097
Das S et al. Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro. 2013 Toxicol. Lett. pmid:24070738
Wu DG et al. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells. 2014 Toxicol. Lett. pmid:24148603
Li Y et al. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. 2018 Toxicol. Lett. pmid:29753067
Ratajewski M et al. Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. 2015 Toxicol. Lett. pmid:25455453
Lim H et al. Flavonoids interfere with NLRP3 inflammasome activation. 2018 Toxicol. Appl. Pharmacol. pmid:29960001
Balasubramanian S and Eckert RL Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin. 2007 Toxicol. Appl. Pharmacol. pmid:17493651
Sarró E et al. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. 2012 Toxicol. Appl. Pharmacol. pmid:22155090
Cheng LC and Li LA Flavonoids exhibit diverse effects on CYP11B1 expression and cortisol synthesis. 2012 Toxicol. Appl. Pharmacol. pmid:22172629
van Meeuwen JA et al. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. 2007 Toxicol. Appl. Pharmacol. pmid:17482226
Gaballah HH et al. Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms. 2017 Toxicol. Appl. Pharmacol. pmid:28025107
Lee WJ et al. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. 2008 Toxicol. Appl. Pharmacol. pmid:17961621
Lecomte S et al. Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation. 2017 Toxicol. Appl. Pharmacol. pmid:28396216
Dai J et al. Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells. 2016 Toxicol. Appl. Pharmacol. pmid:27664007
Wang L et al. Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression. 2013 Toxicol. Appl. Pharmacol. pmid:23743303
Kim DI et al. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds. 2005 Toxicol. Appl. Pharmacol. pmid:15922007
van Meeuwen JA et al. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study. 2008 Toxicol. Appl. Pharmacol. pmid:18201740
Fischer L et al. Potential hazards to embryo implantation: A human endometrial in vitro model to identify unwanted antigestagenic actions of chemicals. 2012 Toxicol. Appl. Pharmacol. pmid:22414680
Gulluce M et al. Isolation of a flavonoid, apigenin 7-O-glucoside, from Mentha longifolia (L.) Hudson subspecies longifolia and its genotoxic potency. 2015 Toxicol Ind Health pmid:23377117
Gulluce M et al. Determination of antimutagenic properties of apigenin-7-O-rutinoside, a flavonoid isolated from Mentha longifolia (L.) Huds. ssp. longifolia with yeast DEL assay. 2013 Toxicol Ind Health pmid:22491724
Heijnen CG et al. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. 2001 Toxicol In Vitro pmid:11259863
Uddin Q et al. The biflavonoid, amentoflavone degrades DNA in the presence of copper ions. 2004 Toxicol In Vitro pmid:15130600
Wakx A et al. New in vitro biomarkers to detect toxicity in human placental cells: The example of benzo[A]pyrene. 2016 Toxicol In Vitro pmid:26657896